IPAD-DB ID | S00113 |
Name | 2B |
Category | Synthetic compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | C 2 7 H 5 0 N . C l C 2 7 H 5 0 C l N |
Molecular Weight | 424.1 g/mol |
IUPAC Name | benzyl-dimethyl-octadecylazanium;chloride |
InChI | InChI=1S/C27H50N.ClH/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-22-25-28(2, 3)26-27-23-20-19-21-24-27;/h19-21, 23-24H, 4-18, 22, 25-26H2, 1-3H3;1H/q+1;/p-1 |
InChIKey | SFVFIFLLYFPGHH-UHFFFAOYSA-M |
Canonical SMILES | CCCCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1.[Cl-] |
PubChem CID | 31204 |
DrugBank Accession Number | - |
CAS Registry Number | 122-19-0 |
Molecular Weight(Computed by SwissADME) | 424.15 |
Hac(Computed by SwissADME) | 29 |
Volume(Computed by ADMETlab 2.0) | 471.397 |
Density(Computed by ADMETlab 2.0) | 0.824 |
nRing(Computed by ADMETlab 2.0) | 1 |
MaxRing(Computed by ADMETlab 2.0) | 6 |
nHet(Computed by ADMETlab 2.0) | 1 |
fChar(Computed by ADMETlab 2.0) | 1 |
nRig(Computed by ADMETlab 2.0) | 6 |
Flexibility(Computed by ADMETlab 2.0) | 3.167 |
Stero Centers(Computed by ADMETlab 2.0) | 0 |
LogS(Computed by ADMETlab 2.0) | -4.961 |
LogD(Computed by ADMETlab 2.0) | 3.433 |
logP(Computed by ADMETlab 2.0) | 8.383 |
TPSA(Computed by SwissADME) | 0 |
Hbond Acceptor(Computed by SwissADME) | 0 |
Hbond Donor(Computed by SwissADME) | 0 |
Rotatable Bonds(Computed by SwissADME) | 19 |
GI Absorption(Computed by SwissADME) | Low |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No |
P-gp Substrate(Computed by SwissADME) | Yes |
CYP1A2 Inhibitor(Computed by SwissADME) | No |
CYP2C19 Inhibitor(Computed by SwissADME) | No |
CYP2C9 Inhibitor(Computed by SwissADME) | No |
CYP2D6 Inhibitor(Computed by SwissADME) | No |
CYP3A4 Inhibitor(Computed by SwissADME) | No |
log Kp(Skin Permeation)(Computed by SwissADME) | -0.79 |
Lipinski(Computed by SwissADME) | 0 |
Ghose(Computed by SwissADME) | 2 |
Veber(Computed by SwissADME) | 1 |
Egan(Computed by SwissADME) | 0 |
Muegge(Computed by SwissADME) | 3 |
Bioavailability Score(Computed by SwissADME) | 0.55 |